AA |
Arachidonic acid |
AD |
Alzheimer’s disease |
ALX/FPR |
Lipoxin A4/formyl peptide receptor |
APP |
Amyloid precursor protein |
Aβ |
Amyloid-beta |
BBB |
Blood-brain barrier |
BLT |
Leukotriene B4 receptor |
ChemR |
Chemerin receptor |
CNS |
Central nervous system |
COX |
Cyclooxygenase |
CSF |
Cerebrospinal fluid |
DHA |
docosahexaenoic |
EPA |
eicosapenraenoic |
GPCR |
G protein-coupled receptor |
GPR |
G protein receptor |
LGR |
Leucine-rich repeat containing G protein-coupled receptor |
LT |
Leukotriene |
LOX |
Lipoxygenase |
LXA4 |
Lipoxin A4 |
MaR1 |
Maresin 1 |
MCI |
Mild cognitive impairment |
MMSE |
Mini-Mental State Examination |
MRI |
Magnetic resonance imaging |
NMDA |
N-methyl-D-aspartate |
NPD1 |
Neuroprotectin D1 |
NSAIDs |
Non-steroidal anti-inflammatory drugs |
PET |
Positron emission tomography |
PG |
Prostaglandin |
PPAR |
Peroxisome proliferator-activated receptor |
PUFA |
Polyunsaturated fatty acid |
RORα |
Retinoic acid-related orphan receptor α |
RvD1 |
Resolvin D1 |
RvE1 |
Resolvin E1 |
SPECT |
Single photon emission computed tomography |
SPM |
Specialized pro-resolving lipid mediator |
TX |
Thromboxane |